p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular Cancer Research

• Publication date

  2014-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-14-0277-TPMID 25512615PMCID PMC4369163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Downregulation of the Mitochondrial Calcium Uniporter by Cancer-Related miR-25

  2013cited by this paper
• Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.

  2013cited by this paper
• The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.

  2013cited by this paper
• Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence.

  2013cited by this paper
• MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme

  2012cited by this paper
• miR‐25 targets TNF‐related apoptosis inducing ligand (TRAIL) death receptor‐4 and promotes apoptosis resistance in cholangiocarcinoma

  2012cited by this paper
• MiR-25 Regulates Wwp2 and Fbxw7 and Promotes Reprogramming of Mouse Fibroblast Cells to iPSCs

  2012cited by this paper
• From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer

  2012cited by this paper
• Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.

  2012cited by this paper
• Tumor suppressor functions of FBW7 in cancer development and progression

  2012cited by this paper
• Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.

  2011cited by this paper
• Survey of MicroRNA expression in pediatric brain tumors

  2011cited by this paper
• MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.

  2011cited by this paper
• Low-Dose Valproic Acid Enhances Radiosensitivity of Prostate Cancer through Acetylated p53-Dependent Modulation of Mitochondrial Membrane Potential and Apoptosis

  2011cited by this paper
• Molecular characterization of neuroendocrine prostate cancer (NEPC) and identification of new drug targets.

  2011influential reference
• PC3 is a cell line characteristic of prostatic small cell carcinoma

  2011cited by this paper
• miRNA expression profiling of lung adenocarcinomas: correlation with mutational status

  2010cited by this paper
• Identification of the miR-106b~25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation

  2010cited by this paper
• Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma.

  2009influential reference
• Modulation of microRNA processing by p53

  2009cited by this paper
• E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer.

  2008cited by this paper
• Aurora-A: the maker and breaker of spindle poles

  2007cited by this paper
• Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation

  2006cited by this paper
• Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin‐dependent degradation

  2006cited by this paper
• Production and purification of lentiviral vectors

  2006cited by this paper
• Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor

  2006cited by this paper
• NDEL1 Phosphorylation by Aurora-A Kinase Is Essential for Centrosomal Maturation, Separation, and TACC3 Recruitment

  2006cited by this paper
• Aurora A activates D-TACC–Msps complexes exclusively at centrosomes to stabilize centrosomal microtubules

  2005cited by this paper
• Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene

  2004cited by this paper
• Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7

  2004influential reference
• The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

  2004influential reference
• Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells

  2003influential reference
• Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase

  2001cited by this paper
• Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA

  2000cited by this paper
• Phosphorylation of CPEB by Eg2 mediates the recruitment of CPSF into an active cytoplasmic polyadenylation complex.

  2000cited by this paper
• A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.

  1995cited by this paper
• The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker".

  1989cited by this paper
• Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate.

  1987cited by this paper

• Panorama: a database for the oncogenic evaluation of somatic mutations in pan-cancer

  2026cites this paper
• CBP/p300, a promising therapeutic target for prostate cancer

  2025cites this paper
• MicroRNAs as the critical regulators of ubiquitin-proteasome system through F-box protein targeting during tumor progression

  2025cites this paper
• Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer.

  2025cites this paper
• Deciphering the Complex Interplay of Long Noncoding RNAs and Aurora Kinases: Novel Insights into Breast Cancer Development and Therapeutic Strategies

  2024cites this paper
• The significant others of aurora kinase a in cancer: combination is the key

  2024cites this paper
• Oncogenic tRNA‐derived fragment tRF‐Leu‐CAG promotes tumorigenesis of lung cancer via targeting TCEA3 and increasing autophagy

  2024cites this paper
• Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide

  2024cites this paper
• Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase.

  2024cites this paper
• Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes

  2024cites this paper
• Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review

  2024cites this paper
• The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer

  2023cites this paper
• Inhibitors Targeting the F-BOX Proteins

  2023cites this paper
• Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution

  2023cites this paper
• The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC

  2022cites this paper
• Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancer

  2022cites this paper
• Clinical significance of FBXW7 loss of function in human cancers

  2022cites this paper
• Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation

  2022cites this paper
• miRNAs in prostate cancer: Intercellular and extracellular communications

  2022cites this paper
• Combination of AURKA inhibitor and HSP90 inhibitor to treat breast cancer with AURKA overexpression and TP53 mutations

  2022cites this paper
• Role of MicroRNAs in Neuroendocrine Prostate Cancer

  2022cites this paper
• Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer

  2021cites this paper
• Exosomal transfer of miR-25-3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7

  2021cites this paper
• Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular Carcinoma by Targeting the DNA Damage Pathway

  2021cites this paper
• Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs

  2021cites this paper
• Homoharringtonine inhibits melanoma cells proliferation in vitro and vivo by inducing DNA damage, apoptosis, and G2/M cell cycle arrest.

  2021cites this paper
• Post-Translational Modifications That Drive Prostate Cancer Progression

  2021cites this paper
• Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer

  2021cites this paper
• Therapy considerations in neuroendocrine prostate cancer: what next?

  2021cites this paper
• MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer

  2020cites this paper
• Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review.

  2020influential citation
• Epigenetic modulations and lineage plasticity in advanced prostate cancer.

  2020cites this paper
• Role of AURKA in the hypothalamus-pituitary-testicular axis in Tibetan sheep from Tianzhu.

  2020cites this paper
• Regulation of F-box proteins by noncoding RNAs in human cancers.

  2019cites this paper
• The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis

  2019cites this paper
• Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway

  2019cites this paper
• NeoTYPE TM Analysis Discovery Profile Client 1234 Sample Hospital

  2019cites this paper
• Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas

  2019cites this paper
• FBXW7 in Cancer: What Has Been Unraveled Thus Far?

  2019cites this paper
• SCFFBXW7/GSK3β-mediated GFI1 degradation suppresses gastric cancer cell proliferation.

  2019cites this paper
• Abrogation of FBW7α-dependent p53 degradation enhances p53's function as a tumor suppressor

  2019cites this paper
• Molecular model for neuroendocrine prostate cancer progression

  2018cites this paper
• A myriad of roles of miR-25 in health and disease

  2018influential citation
• Role of PLK1 signaling pathway genes in gastrointestinal stromal tumors

  2018cites this paper
• FBXW7: a critical tumor suppressor of human cancers

  2018cites this paper
• Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies.

  2018cites this paper
• P53 Gene Mutation Identified by Next Generation Sequencing in Poorly Differentiated Neuroendocrine Carcinoma of the Nasal Cavity

  2018cites this paper
• Inhibition of the Hedgehog signaling pathway suppresses cell proliferation by regulating the Gli2/miR-124/AURKA axis in human glioma cells.

  2017cites this paper
• Aurora kinases: novel therapy targets in cancers

  2017cites this paper
• Emerging Variants of Castration-Resistant Prostate Cancer

  2017cites this paper
• CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4

  2017cites this paper
• The Missing Link in the Diagnostic Pathway of Prostate Cancer

  2017cites this paper
• miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7.

  2017cites this paper
• Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation

  2016cites this paper
• Neuroendocrine Tumors of the Prostate and Molecular Features

  2016cites this paper
• Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer

  2016cites this paper
• Functional Significance of Aurora Kinases–p53 Protein Family Interactions in Cancer

  2016cites this paper
• HPV16 E6 upregulates Aurora A expression

  2016cites this paper
• Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis

  2016cites this paper
• The SCF-type E3 Ubiquitin Ligases as Cancer Targets.

  2016cites this paper
• microRNA-25 Inhibits Cell Apoptosis of Human Gastric Adenocarcinoma Cell Line AGS via Regulating CCNE1 and MYC

  2016cites this paper
• Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

  2016cites this paper
• Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells.

  2016cites this paper
• MicroRNA regulation of F-box proteins and its role in cancer.

  2016cites this paper
• Loss of PKCδ Induces Prostate Cancer Resistance to Paclitaxel through Activation of Wnt/β-Catenin Pathway and Mcl-1 Accumulation

  2016cites this paper
• Expression of mutant p53 in oral squamous cell carcinoma is correlated with the effectiveness of intra-arterial chemotherapy.

  2015cites this paper
• Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.

  2015cites this paper
• Expression of mutant p 53 in oral squamous cell carcinoma is correlated with the effectiveness of intra-arterial chemotherapy

  2015cites this paper
• MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7

  2015cites this paper
• miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL

  2015cites this paper
• MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7

  2015cites this paper
• Neuroendocrine Prostate Cancer

  2013cites this paper